Skip to main content
Erschienen in: Abdominal Radiology 3/2014

01.06.2014

Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

verfasst von: Seung Joon Choi, Jonghoon Kim, Jongbum Seo, Hyung Sik Kim, Jong-min Lee, Hyunjin Park

Erschienen in: Abdominal Radiology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images.

Methods

35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches.

Results

Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87.

Conclusions

We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
Literatur
1.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150. doi:10.1200/JCO.2005.05.2308 PubMedCrossRef Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150. doi:10.​1200/​JCO.​2005.​05.​2308 PubMedCrossRef
3.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430PubMedCrossRef Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430PubMedCrossRef
6.
Zurück zum Zitat Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739. doi:10.1016/S0140-6736(02)08649-X PubMedCrossRef Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739. doi:10.​1016/​S0140-6736(02)08649-X PubMedCrossRef
7.
Zurück zum Zitat Nakao N, Uchida H, Kamino K, et al. (1992) Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S72–S76CrossRef Nakao N, Uchida H, Kamino K, et al. (1992) Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S72–S76CrossRef
8.
Zurück zum Zitat Kanematsu T, Furuta T, Takenaka K, et al. (1989) A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10(1):98–102PubMedCrossRef Kanematsu T, Furuta T, Takenaka K, et al. (1989) A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10(1):98–102PubMedCrossRef
9.
Zurück zum Zitat Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214PubMedCrossRef Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214PubMedCrossRef
12.
Zurück zum Zitat Jinno K, Moriwaki S, Tanada M, et al. (1992) Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S7–S12PubMedCrossRef Jinno K, Moriwaki S, Tanada M, et al. (1992) Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S7–S12PubMedCrossRef
13.
Zurück zum Zitat Imaeda T, Yamawaki Y, Seki M, et al. (1993) Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Interv Radiol 16(4):209–213CrossRef Imaeda T, Yamawaki Y, Seki M, et al. (1993) Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Interv Radiol 16(4):209–213CrossRef
15.
Zurück zum Zitat Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713. doi:10.1148/radiology.182.3.1311116 PubMed Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713. doi:10.​1148/​radiology.​182.​3.​1311116 PubMed
18.
20.
Zurück zum Zitat Galban CJ, Mukherji SK, Chenevert TL, et al. (2009) A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2(3):184–190PubMedCentralPubMedCrossRef Galban CJ, Mukherji SK, Chenevert TL, et al. (2009) A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2(3):184–190PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Hmastra DA, Chenevert TL, Moffat BA, et al. (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102(46):16759–16764CrossRef Hmastra DA, Chenevert TL, Moffat BA, et al. (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102(46):16759–16764CrossRef
24.
Zurück zum Zitat Kubota K, Hisa N, Nishikawa T, et al. (2001) Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26(2):184–190PubMedCrossRef Kubota K, Hisa N, Nishikawa T, et al. (2001) Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26(2):184–190PubMedCrossRef
25.
Zurück zum Zitat Lee JK, Chung YH, Song BC, et al. (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17(1):52–58PubMedCrossRef Lee JK, Chung YH, Song BC, et al. (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17(1):52–58PubMedCrossRef
26.
Zurück zum Zitat Park W, Chung YH, Kim JA, et al. (2013) Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: focused on the recurrence patterns. Hepatol Res 43(12):1304–1312. doi:10.1111/hepr.12083 PubMedCrossRef Park W, Chung YH, Kim JA, et al. (2013) Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: focused on the recurrence patterns. Hepatol Res 43(12):1304–1312. doi:10.​1111/​hepr.​12083 PubMedCrossRef
27.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216PubMedCrossRef Therasse P, Arbuck SG, Eisenhauer EA, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216PubMedCrossRef
28.
Zurück zum Zitat Meyer CR, Boes JL, Kim B, et al. (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1(3):195–206PubMedCrossRef Meyer CR, Boes JL, Kim B, et al. (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1(3):195–206PubMedCrossRef
29.
Zurück zum Zitat Cover TM, Hart PE (1967) Nearest neighbor pattern classification. IEEE Trans Inf Theor 13(1):21–27CrossRef Cover TM, Hart PE (1967) Nearest neighbor pattern classification. IEEE Trans Inf Theor 13(1):21–27CrossRef
30.
32.
33.
Zurück zum Zitat Kagawa T, Koizumi J, Kojima S, et al. (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116(15):3638–3644. doi:10.1002/cncr.25142 PubMedCrossRef Kagawa T, Koizumi J, Kojima S, et al. (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116(15):3638–3644. doi:10.​1002/​cncr.​25142 PubMedCrossRef
36.
37.
Zurück zum Zitat Chung YH, Han G, Yoon JH, et al. (2013) Interim analysis of START: study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial. Int J Cancer 132(10):2448–2458. doi:10.1002/ijc.27925 PubMedCrossRef Chung YH, Han G, Yoon JH, et al. (2013) Interim analysis of START: study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial. Int J Cancer 132(10):2448–2458. doi:10.​1002/​ijc.​27925 PubMedCrossRef
38.
Zurück zum Zitat Cui HZ, Dai GH, Shi Y, et al. (2013) Sorafenib combined with TACE in advanced primary hepatocellular carcinoma. Hepatogastroenterology 60(122):305–310. doi:10.5754/hge12552 PubMed Cui HZ, Dai GH, Shi Y, et al. (2013) Sorafenib combined with TACE in advanced primary hepatocellular carcinoma. Hepatogastroenterology 60(122):305–310. doi:10.​5754/​hge12552 PubMed
39.
Zurück zum Zitat Zhao JD, Liu J, Ren ZG, et al. (2010) Maintenance of sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol 5:12. doi:10.1186/1748-717X-5-12 PubMedCentralPubMedCrossRef Zhao JD, Liu J, Ren ZG, et al. (2010) Maintenance of sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol 5:12. doi:10.​1186/​1748-717X-5-12 PubMedCentralPubMedCrossRef
40.
41.
Zurück zum Zitat Meyer D, Leisch F, Hornik K (2003) The support vector machine under test. Neurocomputing 55(1):169–186CrossRef Meyer D, Leisch F, Hornik K (2003) The support vector machine under test. Neurocomputing 55(1):169–186CrossRef
Metadaten
Titel
Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization
verfasst von
Seung Joon Choi
Jonghoon Kim
Jongbum Seo
Hyung Sik Kim
Jong-min Lee
Hyunjin Park
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 3/2014
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0087-z

Weitere Artikel der Ausgabe 3/2014

Abdominal Radiology 3/2014 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.